The pharmaceutical companies, which have been engaged in the production of these drugs, were issued notices and have been directed to rectify the manufacturing processes, the pharmabiz reported.
The 24 drugs include Domal AR manufactured by Grig Formulations in Baddi, Ampef D capsules by Pinnacle Life Sciences, Solan Himachal Pradesh, diclofenac injection by Hindustan Pharmaceuticals’ in Bihar, Klor-con by Himalaya Medicals, Deharadun, Resveratrol by Intervet in Pune.
Drug Control Department drugs controller BR Jagashetty was quoted by the news agency as saying that the drugs department has sent notes of caution to the 25,500 chemists and wholesalers apart from the hospitals and the public to refrain from stocking and prescribing the drugs.
The drugs found to be not-of-standard quality contains active pharmaceutical ingredients below 70% for thermo liable products and below 5% of the permitted limits for the thermo stable products, according to a section of scientists.
Â